| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Goldan Keith A. is a Chief Financial Officer at Syndax Pharmaceuticals Inc with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 4 sells.
Estimated insider holdings value: $3.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | SNDX Syndax Pharmaceuticals Inc | Chief Financial Officer | Sell | 3,410 | $21.03 | $71,705.48 | -2.4% | - | - | |
| Jul 16, 2025 | SNDX Syndax Pharmaceuticals Inc | Chief Financial Officer | Sell | 1,296 | $9.29 | $12,033.36 | -1.4% | +65.5% | - | |
| May 19, 2025 | SNDX Syndax Pharmaceuticals Inc | Chief Financial Officer | Buy | 3,000 | $0.00 | - | +3.3% | +70.6% | - | |
| Feb 10, 2025 | SNDX Syndax Pharmaceuticals Inc | Chief Financial Officer | Sell | 3,777 | $15.50 | $58,558.61 | -4.0% | -27.4% | +40.9% | |
| Jun 14, 2024 | SNDX Syndax Pharmaceuticals Inc | Chief Financial Officer | Buy | 1,250 | $20.03 | $25,037.25 | +2.4% | -10.5% | -49.0% | |
| Jun 13, 2023 | SNDX Syndax Pharmaceuticals Inc | Chief Financial Officer | Sell | 577 | $22.31 | $12,872.87 | -18.0% | -22.2% | -9.1% |